Literature DB >> 12393852

Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells.

Kohshi Ohishi1, Barbara Varnum-Finney, Irwin D Bernstein.   

Abstract

We investigated the effect of Notch signaling, a known regulator of cell fate in numerous developmental systems, on human hematopoietic precursors. We show that activation of endogenous Notch signaling in human CD34(+)CD38(-) cord blood precursors with immobilized Delta-1 in serum-free cultures containing fibronectin and hematopoietic growth factors inhibited myeloid differentiation and induced a 100-fold increase in the number of CD34(+) cells compared with control cultures. Immobilized Delta-1 also induced a multifold expansion of cells with the phenotype of common lymphoid precursors (CD34(+)CD7(+)CD45RA(+)) and promoted the development of cytoplasmic CD3(+) T/NK cell precursors. IL-7 enhanced the promotion of T/NK cell differentiation by immobilized Delta-1, but granulocytic differentiation occurred when G-CSF was added. Transplantation into immunodeficient mice showed a substantial increase in myeloid and B cell engraftment in the marrow and also revealed thymic repopulation by CD3(+) T cells due to cells being cultured for a longer period with immobilized Delta-1. These data suggest that Delta-1 can enhance myeloid and lymphoid marrow-repopulating ability and promote the generation of thymus-repopulating T cell precursors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393852      PMCID: PMC150801          DOI: 10.1172/JCI16167

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.

Authors:  H Glimm; W Eisterer; K Lee; J Cashman; T L Holyoake; F Nicolini; L D Shultz; C von Kalle; C J Eaves
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Microenvironmental influences on human B-cell development.

Authors:  F E Bertrand; C E Eckfeldt; J R Fink; A S Lysholm; J A Pribyl; N Shah; T W LeBien
Journal:  Immunol Rev       Date:  2000-06       Impact factor: 12.988

3.  Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells.

Authors:  B Canque; S Camus; A Dalloul; E Kahn; M Yagello; C Dezutter-Dambuyant; D Schmitt; C Schmitt; J C Gluckman
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

4.  Distinct requirements for optimal growth and In vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells.

Authors:  V Ramsfjell; D Bryder; H Björgvinsdóttir; S Kornfält; L Nilsson; O J Borge; S E Jacobsen
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

5.  Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1.

Authors:  K Ohishi; B Varnum-Finney; D Flowers; C Anasetti; D Myerson; I D Bernstein
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

6.  Mouse Jagged2 is differentially expressed in hematopoietic progenitors and endothelial cells and promotes the survival and proliferation of hematopoietic progenitors by direct cell-to-cell contact.

Authors:  S Tsai; J Fero; S Bartelmez
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

7.  Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling.

Authors:  B Varnum-Finney; L Xu; C Brashem-Stein; C Nourigat; D Flowers; S Bakkour; W S Pear; I D Bernstein
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

8.  Notch1 expression in early lymphopoiesis influences B versus T lineage determination.

Authors:  J C Pui; D Allman; L Xu; S DeRocco; F G Karnell; S Bakkour; J Y Lee; T Kadesch; R R Hardy; J C Aster; W S Pear
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

9.  Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling.

Authors:  B Varnum-Finney; L Wu; M Yu; C Brashem-Stein; S Staats; D Flowers; J D Griffin; I D Bernstein
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

10.  The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells.

Authors:  F N Karanu; B Murdoch; L Gallacher; D M Wu; M Koremoto; S Sakano; M Bhatia
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  65 in total

1.  NOTCH-Mediated Maintenance and Expansion of Human Bone Marrow Stromal/Stem Cells: A Technology Designed for Orthopedic Regenerative Medicine.

Authors:  Yufeng Dong; Teng Long; Cuicui Wang; Anthony J Mirando; Jianquan Chen; Regis J O'Keefe; Matthew J Hilton
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

2.  Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation.

Authors:  Jiaxue Huang; Karla P Garrett; Rosana Pelayo; Juan Carlos Zúñiga-Pflücker; Howard T Petrie; Paul W Kincade
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

Review 3.  Notch signaling in hematopoietic stem cells.

Authors:  Takahiro Suzuki; Shigeru Chiba
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

Review 4.  Paradigms of notch signaling in mammals.

Authors:  Alexis Dumortier; Anne Wilson; H Robson MacDonald; Freddy Radtke
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

5.  Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1.

Authors:  Mari H Dallas; Barbara Varnum-Finney; Paul J Martin; Irwin D Bernstein
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

Review 6.  Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation.

Authors:  J L Zakrzewski; A M Holland; M R M van den Brink
Journal:  J Mol Med (Berl)       Date:  2007-02-28       Impact factor: 4.599

Review 7.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

Review 8.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

10.  A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development.

Authors:  Brandon K Hadland; Stacey S Huppert; Jyotshnabala Kanungo; Yingzi Xue; Rulang Jiang; Thomas Gridley; Ronald A Conlon; Alec M Cheng; Raphael Kopan; Gregory D Longmore
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.